Drug group Sinclair Pharma (LSE: SPH.L - news) has announced the transformation its dermatology business through the acquisition of France’s Groupe CS Dermatologie alongside its latest interim figures.
Drug group Sinclair Pharma (LSE: SPH.L - news) has announced the transformation its dermatology business through the acquisition of France’s Groupe CS Dermatologie alongside its latest interim figures.